| Item Type | Name |
|
Academic Article
|
Association of the tissue kallikrein gene promoter with ESRD and hypertension.
|
|
Academic Article
|
Surgical management of atherosclerotic renovascular disease.
|
|
Academic Article
|
Impact of birth weight on familial aggregation of end-stage renal disease.
|
|
Academic Article
|
Susceptibility genes for hypertension and renal failure.
|
|
Academic Article
|
Linkage analysis of diabetes status among hypertensive families: the Hypertension Genetic Epidemiology Network study.
|
|
Academic Article
|
The relationship between albuminuria and hormone therapy in postmenopausal women.
|
|
Academic Article
|
Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus.
|
|
Academic Article
|
Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
|
|
Academic Article
|
Evaluation of genetic association and expression reduction of TRPC1 in the development of diabetic nephropathy.
|
|
Academic Article
|
Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study.
|
|
Academic Article
|
The spectrum of MYH9-associated nephropathy.
|
|
Academic Article
|
Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.
|
|
Academic Article
|
Target organ damage in African American hypertension: role of APOL1.
|
|
Academic Article
|
Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
|
|
Academic Article
|
End-stage renal failure in African Americans: insights in kidney disease susceptibility.
|
|
Academic Article
|
A genome-wide scan for urinary albumin excretion in hypertensive families.
|
|
Academic Article
|
A genome scan for ESRD in black families enriched for nondiabetic nephropathy.
|
|
Academic Article
|
The impact of pedigree structure on heritability estimates for pulse pressure in three studies.
|
|
Academic Article
|
Quantitative trait loci on chromosome 8q24 for pancreatic beta-cell function and 7q11 for insulin sensitivity in obese nondiabetic white and black families: evidence from genome-wide linkage scans in the NHLBI Hypertension Genetic Epidemiology Network (HyperGEN) study.
|
|
Academic Article
|
Plasma adiponectin concentrations and correlates in African Americans in the Hypertension Genetic Epidemiology Network (HyperGEN) study.
|
|
Academic Article
|
Chromogranin A polymorphisms are associated with hypertensive renal disease.
|
|
Academic Article
|
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.
|
|
Academic Article
|
Hypertension-associated kidney disease: perhaps no more.
|
|
Academic Article
|
Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.
|
|
Academic Article
|
Essential hypertension and risk of nephropathy: a reappraisal.
|
|
Academic Article
|
Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
|
|
Academic Article
|
Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
|
|
Academic Article
|
Intensive blood-pressure control in hypertensive chronic kidney disease.
|
|
Academic Article
|
Genome-wide detection of allele specific copy number variation associated with insulin resistance in African Americans from the HyperGEN study.
|
|
Academic Article
|
Novel findings and future directions on the genetics of hypertension.
|
|
Academic Article
|
Effects of rare and common blood pressure gene variants on essential hypertension: results from the Family Blood Pressure Program, CLUE, and Atherosclerosis Risk in Communities studies.
|
|
Academic Article
|
Salt sensitivity: a review with a focus on non-Hispanic blacks and Hispanics.
|
|
Concept
|
Hypertension, Renal
|
|
Concept
|
Hypertension
|
|
Concept
|
Hypertension, Renovascular
|
|
Academic Article
|
APOL1 risk variants, race, and progression of chronic kidney disease.
|
|
Academic Article
|
Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study.
|
|
Academic Article
|
Cerebral structural changes in diabetic kidney disease: African American-Diabetes Heart Study MIND.
|
|
Academic Article
|
APOL1 and kidney disease: new insights leading to novel therapies.
|
|
Academic Article
|
Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107.
|
|
Academic Article
|
Relationships between Cognitive Performance, Neuroimaging and Vascular Disease: The DHS-MIND Study.
|
|
Academic Article
|
Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.
|
|
Academic Article
|
Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
|
|
Academic Article
|
Hypertension-attributed nephropathy: what's in a name?
|
|
Academic Article
|
APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.
|
|
Academic Article
|
Genetics: Genetic factors in the regulation of blood pressure.
|
|
Academic Article
|
Research Needs to Improve Hypertension Treatment and Control in African Americans.
|
|
Grant
|
Natural History of MYH9-Associated Nephropathy
|
|
Grant
|
GENETIC ANALYSIS OF HUMAN HYPERTENSIVE ESRD
|
|
Grant
|
An Integrative Genomic Approach to APOL1-Associated Nephropathy.
|
|
Academic Article
|
Effects of Intensive BP Control in CKD.
|
|
Academic Article
|
Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.
|
|
Academic Article
|
Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.
|
|
Academic Article
|
Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
|
|
Academic Article
|
Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.
|
|
Academic Article
|
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).
|
|
Academic Article
|
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
|
|
Academic Article
|
Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.
|
|
Academic Article
|
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.
|
|
Academic Article
|
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.
|
|
Academic Article
|
The Impact of APOL1 on Chronic Kidney Disease and Hypertension.
|
|
Academic Article
|
Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial.
|
|
Academic Article
|
Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
|
|
Academic Article
|
Effects of Intensive Systolic Blood Pressure Control on All-Cause Hospitalizations.
|